Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

Study Identifier
P16-489
CT.gov Identifier
NCT03310190
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Blood Cancer - Chronic Lymphocytic Leukemia (CLL)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patient's physician prescribed venetoclax as per product monograph independent of the patient participation in this study. * Has chronic lymphocytic leukemia (CLL) and has received at least one prior therapy.
    Exclusion Criteria:
    * Currently participating in an interventional study. * Has other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of CLL.

    Protocol Summary

    A study to assess the real-life management and use of healthcare resources during the initiation of:

    • Venetoclax in combination with rituximab is indicated for the treatment of adult participants with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
    • Venetoclax in participants with CLL with the deletion of the short arm of chromosome 17 (del\[17p\]) who have received at least 1 prior therapy or participants with CLL without del(17p) who have received at least 1 prior therapy and for whom there are no other available treatment options.

    Study Locations

    Location
    Status
    Location
    University of Calgary /ID# 166416
    Calgary, Alberta, Canada, T2N 4Z6
    Status
    Not applicable
    Location
    Cross Cancer Institute /ID# 166417
    Edmonton, Alberta, Canada, T6G 1Z2
    Status
    Not applicable
    Location
    Jack Ady Cancer Centre /ID# 217491
    Lethbridge, Alberta, Canada, T1J 1W5
    Status
    Not applicable
    Location
    CancerCare Manitoba /ID# 170751
    Winnipeg, Manitoba, Canada, R3E 0V9
    Status
    Not applicable
    Location
    The Moncton Hospital /ID# 166043
    Moncton, New Brunswick, Canada, E1C 6Z8
    Status
    Not applicable
    Location
    QE II Health Sciences Centre /ID# 213548
    Halifax, Nova Scotia, Canada, B3H 1V7
    Status
    Not applicable
    Showing {first} - {last} of {total} Results